308 related articles for article (PubMed ID: 28483541)
1. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients.
Gavand PE; Serio I; Arnaud L; Costedoat-Chalumeau N; Carvelli J; Dossier A; Hinschberger O; Mouthon L; Le Guern V; Korganow AS; Poindron V; Gourguechon C; Lavigne C; Maurier F; Labro G; Heymonet M; Artifoni M; Viau AB; Deligny C; Sene T; Terriou L; Sibilia J; Mathian A; Bloch-Queyrat C; Larroche C; Amoura Z; Martin T
Autoimmun Rev; 2017 Jul; 16(7):743-749. PubMed ID: 28483541
[TBL] [Abstract][Full Text] [Related]
2. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report.
Tulbă D; Balea M; Băicuş C
Rom J Intern Med; 2018 Mar; 56(1):67-70. PubMed ID: 28918421
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
5. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.
Liu AC; Yang Y; Li MT; Jia Y; Chen S; Ye S; Zeng XZ; Wang Z; Zhao JX; Liu XY; Zhu J; Zhao Y; Zeng XF; Li ZG
Clin Rheumatol; 2018 Jan; 37(1):93-100. PubMed ID: 28409239
[TBL] [Abstract][Full Text] [Related]
6. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
[TBL] [Abstract][Full Text] [Related]
7. [The clinical characteristics of macrophage activation syndrome secondary to systemic lupus erythematosus].
Jiang N; Li MT; Wu D; Zeng XF
Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):840-844. PubMed ID: 27801337
[No Abstract] [Full Text] [Related]
8. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases].
Luo ZJ; Wu JJ; Song Y; Mei CL; DU R
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1111-1117. PubMed ID: 38101797
[TBL] [Abstract][Full Text] [Related]
9. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
[TBL] [Abstract][Full Text] [Related]
10. Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus.
Junga Z; Stitt R; Tracy C; Keith M
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28827301
[TBL] [Abstract][Full Text] [Related]
11. In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome.
Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
Semin Arthritis Rheum; 2017 Oct; 47(2):216-221. PubMed ID: 28268026
[TBL] [Abstract][Full Text] [Related]
12. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus.
Dey S; Roongta R; Mondal S; Haldar S; Sircar G; Ghosh B; Ghosh A
Lupus; 2022 Aug; 31(9):1132-1137. PubMed ID: 35713230
[No Abstract] [Full Text] [Related]
13. Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center.
Dall'Ara F; Cavazzana I; Frassi M; Taraborelli M; Fredi M; Franceschini F; Andreoli L; Rossi M; Cattaneo C; Tincani A; Airò P
Reumatismo; 2018 Jul; 70(2):100-105. PubMed ID: 29976044
[TBL] [Abstract][Full Text] [Related]
14. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
15. Macrophage activation syndrome: A severe and frequent manifestation of acute pancreatitis in 362 childhood-onset compared to 1830 adult-onset systemic lupus erythematosus patients.
Gormezano NW; Otsuzi CI; Barros DL; da Silva MA; Pereira RM; Campos LM; Borba EF; Bonfá E; Silva CA
Semin Arthritis Rheum; 2016 Jun; 45(6):706-10. PubMed ID: 26833399
[TBL] [Abstract][Full Text] [Related]
16. Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis.
Bennett TD; Fluchel M; Hersh AO; Hayward KN; Hersh AL; Brogan TV; Srivastava R; Stone BL; Korgenski EK; Mundorff MB; Casper TC; Bratton SL
Arthritis Rheum; 2012 Dec; 64(12):4135-42. PubMed ID: 22886474
[TBL] [Abstract][Full Text] [Related]
17. Case of using mycophenolate in combination with steroids for concurrent macrophage activation syndrome and lupus flare.
Shah K; Porter A; Takhar G; Reddy V
BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32269047
[TBL] [Abstract][Full Text] [Related]
18. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.
Parodi A; Davì S; Pringe AB; Pistorio A; Ruperto N; Magni-Manzoni S; Miettunen P; Bader-Meunier B; Espada G; Sterba G; Ozen S; Wright D; Magalhães CS; Khubchandani R; Michels H; Woo P; Iglesias A; Guseinova D; Bracaglia C; Hayward K; Wouters C; Grom A; Vivarelli M; Fischer A; Breda L; Martini A; Ravelli A;
Arthritis Rheum; 2009 Nov; 60(11):3388-99. PubMed ID: 19877067
[TBL] [Abstract][Full Text] [Related]
19. Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus.
Aoyama-Maeda N; Horino T; Ichii O; Terada Y
Rom J Intern Med; 2018 Jun; 56(2):117-121. PubMed ID: 29099692
[TBL] [Abstract][Full Text] [Related]
20. Macrophage activation syndrome as the initial manifestation of severe juvenile onset systemic lupus erythematosus. Favorable response to cyclophosphamide.
Torres Jiménez A; Solís Vallejo E; Zeferino Cruz M; Céspedes Cruz A; Sánchez Jara B
Reumatol Clin; 2014; 10(5):331-5. PubMed ID: 24035795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
